Site içinde arama yapın

bir ses eklendi Health

2026-01-23 09:12:09 -

Radiopharmaceutical Theranostics Market: Is 2026 the Year "Search and Destroy" Medicine Becomes the Standard of Care?

As of January 23, 2026, the radiopharmaceutical theranostics market is identifying as the "fifth pillar" of cancer treatment, with its 2026 valuation projected to reach approximately $3.27 billion to $6.18 billion globally. The 2026 landscape is defined by a massive CAGR of up to 27.9%, driven by the clinical success of "Radioligand Therapies" that combine diagnostic imaging and therapeutic...

0 Yorumlar 0 hisse senetleri 620 Views 0 önizleme